Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan
This study is looking at two ways to treat severe depression, especially when someone is having thoughts of harming themselves. The treatments are called electroconvulsive therapy (ECT) and ketamine. This is a very important area because people with this type of depression need help quickly. The study wants to compare how effective these two treatments are. Currently, doctors don't always have enough clear information to decide which treatment to suggest first, and patients might be unsure too. This research aims to provide clearer guidance for doctors and patients, so that more people can get the right help faster and reduce the risk of harm after leaving the hospital.
At a glance
What is this study about?
Imagine someone is going through a really tough time with their mental health, feeling very low and having thoughts of harming themselves. This is a serious situation called Acute Suicidal Depression (ASD), and it needs quick help. At the moment, when people are admitted to hospital for this, they might get talking therapies and regular antidepressants, but these can take many weeks to start working. Often, they are sent home quite quickly once immediate danger seems to have passed, but this time just after leaving hospital can be very risky if the depression hasn't really improved.
There are two treatments that can work quickly: electroconvulsive therapy (ECT) and a special type of ketamine treatment. However, doctors don't have enough clear information from big studies to know for sure which one to offer first, or which works best for different people. Patients also might worry about these treatments because they don't know much about them or are concerned about side effects or what others might think. This lack of information means these helpful treatments aren't used as much as they could be.
This study, called "Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan," wants to fill this gap. It's designed to compare ECT and ketamine directly, to see which one works better, or if they are equally good, at quickly lifting this severe depression. The goal is to give doctors and patients better information so they can make more informed decisions and people can get effective help faster when they need it most.
Key takeaways
- Compares two treatments: ECT and ketamine for severe depression.
- Focuses on quick relief when someone is having thoughts of harming themselves.
- Aims to provide clearer guidance for doctors and patients.
- Participants are randomly assigned to one of the two treatments.
- Study helps understand which treatment works best, or if they're equally effective.
- You can stop participating at any time.
Who may be eligible?
To be considered for this study, you would need to be an adult between the ages of 18 and 90 years old. A doctor would need to think that you would benefit from a quick treatment for severe depression where you are having thoughts of harming yourself. You would also need to meet specific criteria for major depression based on a detailed interview and have certain scores on questionnaires that measure your mood and thoughts of self-harm. You would also need to be able to understand and agree to take part in the study.
There are some reasons why you wouldn't be able to join. For example, if you have certain mental health conditions like schizophrenia. You also wouldn't be able to participate if you can't give your informed consent, which means understanding what the study involves and agreeing to it. There are also specific health conditions that would prevent you from having ECT or ketamine treatment, such as being pregnant or breastfeeding, having a severe uncontrolled medical illness, or an allergy to ketamine. Also, if you have delusions or hallucinations as part of your depression, or significant problems with your thinking or understanding, you wouldn't be able to join.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 90 years old?
- Has your doctor suggested you need quick help for severe depression with thoughts of harming yourself?
- Are you able to understand and agree to take part in medical research?
- Do you have any conditions that would prevent you from having ECT or ketamine treatment (e.g., pregnancy, severe uncontrolled illness, allergy to ketamine)?
- Do you have any mental health conditions like schizophrenia?
What does participation involve?
This study is a Phase 4 trial, which means the treatments involved are already available but more information is needed about how well they compare. If you join, you would be randomly assigned to receive either ECT or ketamine treatment. You would know which treatment you are getting, but the doctors who assess your progress at certain points might not. The study involves regular check-ups and assessments to see how your symptoms are changing. The specific details of how many visits, what assessments, and the overall duration would be explained thoroughly, but the main goal is to compare the effectiveness of these two established treatments for your condition.
Potential risks and benefits
Locations (10)
- UC San FranciscoVerified postcodeSan Francisco, United States
- Johns Hopkins UniversityVerified postcodeBaltimore, United States
- McLean HospitalVerified postcodeBelmont, United States
- Massachusetts General HospitalVerified postcodeBoston, United States
- Mount Sinai School of MedicineVerified postcodeNew York, United States
- Cleveland ClinicVerified postcodeCleveland, United States
- University of PittsburghVerified postcodePittsburgh, United States
- UTHealth HoustonVerified postcodeHouston, United States
- University of UtahVerified postcodeSalt Lake City, United States
- Center for Addiction and Mental Health (University of Toronto)Verified postcodeToronto, Canada
Common questions
What is the main goal of this study?
The study aims to compare how well ECT and ketamine treatments work in quickly helping people with severe depression and thoughts of harming themselves.
Will I get to choose which treatment I receive?
No, you will be randomly assigned to receive either ECT or ketamine treatment, like flipping a coin, to ensure a fair comparison.
What are ECT and ketamine?
ECT (Electroconvulsive Therapy) uses controlled electrical currents to cause a brief seizure in the brain. Ketamine in this study is a special anaesthetic drug given at a lower dose through a drip.
Is this a new treatment being tested?
No, both ECT and ketamine are established treatments for depression. This study is comparing them to see which is more effective for severe depression with suicidal thoughts.
What happens if I want to stop participating?
You can leave the study at any time, for any reason. Your decision will not affect your ongoing medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.